The FDA has received reports of serious adverse events which describe medication dosing inaccuracies and other mechanical problems with the pump that have led to patient injury and death. The Food and ...

The US Food and Drug Administration (FDA) has received reports of serious adverse events, including patient injury and death, associated with the use of implantable infusion pumps in the magnetic ...

Iradimed picked up an FDA nod for its MRI-compatible intravenous infusion pump system, which enables patients who can’t be disconnected from IV medication to undergo MRI scanning. The company will now ...

iRadimed, which makes non-magnetic MRI-safe IV infusion pumps, raised $13 million by offering 2.0 million shares at $6.25, above the $5 to $6 range. iRadimed will list on the NASDAQ under the symbol ...

KRAS-mutated tumors were once untreatable. In fact, KRAS was something of a poster child for so-called undruggability. Several laboratories are investigating... With a U.S. biotech identified as One ...

Management raised Q4 2025 revenue guidance to $21.4 million to $22.4 million and GAAP diluted EPS guidance to $0.43 to $0.47, with non-GAAP diluted EPS of $0.47 to $0.50. For full year 2025, guidance ...